Significance of Serum Prostate Specific Antigen with Histopathological Grading in Men with Prostate adenocarcinoma at Makassar, Indonesia
Keywords:Serum PSA, Gleason score, histopathological grading, prostate adenocarcinoma
Prostate adenocarcinoma is the second most common malignancy in men after lung cancer worldwide. In Makassar, South Sulawesi, prostate adenocarcinoma cases increased significantly, from 2017, 2018 and 2019 respectively, the cases reached 31, 43 and 51 cases. Although not specific, Prostate Specific Antigen (PSA) is the first-line test in the screening of prostate adenocarcinoma. Gleason grading is one of the most powerful predictors of biological behavior and when combined PSA with Gleason score and clinical stage. It improves the prediction of the pathological stage for prostate carcinoma. The aim of this study was to determine the association between serum PSA concentration and the new (2016 modified) This was a retrospective study of the correlation between age of patients, serum PSA and grade group of Gleason score of patients diagnosed as Prostate Adenocarcinoma with HE staining at Anatomical Pathology Laboratory, Faculty of Medicine, Hasanuddin University. The age of patients and the serum PSA values were retrieved from laboratory files. Histological slides of appropriate cases were reviewed to confirm the Gleason score and group grade. There were 27 cases fulfilled criteria, from September 2020 to November 2021. The data obtained were subjected to statistical analysis to look for associations and correlations serum PSA and group grade of prostate adenocarcinoma. This study showed that there was a significant correlation between serum PSA level with histopathological grading based on Gleason score of prostate adenocarcinoma (p<0,05).
. Rawla P. Epidemiology of Prostate Cancer. 2019;10(2):63-89.
. InfoDATIN. PUSAT DATA DAN INFORMASI KEMENTERIAN KESEHATAN RI. 2015:1-6.
. Adebayo L. Correlation of Serum PSA with Gleason Score and Gleason Group Grade in Patients with Prostate Adenocarcinoma at Sokoto North-Western Nigeria. 2020;(September).
. Tikkinen KAO, Dahm P, Lytvyn L, et al. Prostate cancer screening with prostate-specific antigen ( PSA ) test : a clinical practice guideline. 2018. doi:10.1136/bmj.k3581
. Palsdottir T, Nordstrom T, Karlsson A, Grönberg H, Clements M, Eklund M. The impact of different prostate-specific antigen ( PSA ) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations : a population-based cohort study. 2019:1-8. doi:10.1136/bmjopen-2018-027958
. Okolo CA, Akinosun OM, Shittu OB. Correlation of Serum PSA and Gleason Score in Nigerian Men with Prostate Cancer. 2008;14(1):15-22.
. Kosei T, Hospital N. Clinical Use of Prostate Specific Antigen ( PSA ). 2004;130(2):549-554.
. Paper O, Ceylan C, Gazel E. Can the Free / Total PSA Ratio Predict the Gleason Score Before Prostate Biopsy ? 2016:24-27. doi:10.1159/000442846
. Humphrey PA, Amin MB, Berney DM, Billis A, Cao D, Cheng L et al. WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE WHO Blue Books : History TUMOURS OF THE PROSTATE. In: Acinar Adenocarcinoma. 4th editio. Lyon Cedex 08, France: International Agency for Research on Cancer (IARC); 2016:135-183.
. Kryvenko ON, Epstein JI. Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System. Arch Pathol Lab Med. 2016;140(10):1140-1152. doi:10.5858/arpa.2015-0487-SA
. Pepe P, Pennisi M. Gleason score stratification according to age at diagnosis in 1028 men. 2014;18:9-11. doi:10.5114/wo.2015.56654
. Prostate F, Early C, Prostate C, et al. Prostate Cancer Early Detection , Diagnosis , and Staging Can Prostate Cancer Be Found Early ? :1-39.
. Kryvenko ON, Epstein JI. Prostate Cancer Grading A Decade After the 2005 Modified Gleason Grading System Oleksandr. Arch Pathol Lab Me. 2016;(College of American Pathologists):1-14. doi:10.5858/arpa.2015-0487-SA
. Nnabugwu I, Udeh E, Ugwumba FO, Ozoemne FO. Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria. Dove Press J. 2016:961-966.
How to Cite
Authors who submit papers with this journal agree to the following terms.